Fall 2001 Seminar Series

STAT 598E: Statistical Applications in Pharmaceutical Research and Development

Mondays, 4:30 PM, LAEB B222

This special seminar series, which focuses on statistical methods and issues in the pharmaceutical industry, is a joint initiative between the Statistical and Mathematical Sciences Department of Eli Lilly & Company and the Department of Statistics of Purdue University at West Lafayette, Indiana. The lectures will be given by a team of Eli Lilly statisticians.

The goal of the series is to introduce students and faculty at the university to the broad spectrum of issues surrounding the drug development process in a pharmaceutical industry. The gamut of activities covering discovery, development, manufacturing, and marketing of pharmaceutical agents will be discussed. The statistical content of the seminars will be directed to students knowledgeable about statistics as well as the general interested audience.

The series is also offered as a one credit course, labeled STAT 598E, for Fall 2001 at Purdue. The instructor and coordinator is Professor M.E. Bock and the prerequisite is an introductory statistics course. The course meets Mondays, 4:30 PM, in LAEB B222. For further information, please contact Professor Bock by email at mbock@stat.purdue.edu or by phone at 765-494-3141.

The first seminar is Monday, August 20, 2001, 4:30 PM, LAEB B222.

Schedule

Monday, August 20, 2001, 4:30 PM in LAEB B222
Dr. J. P. Wery, Eli Lilly & Company
Overview of Drug Discovery and Development. Role of Statistics and Information Sciences

Monday, August 27, 2001, 4:30 PM in LAEB B222
Dr. Ann Marie Crawford, Eli Lilly & Company
Drug Hunting: Impact and Influence of Statistical Science on Regulated Drug Development

Monday, September 10, 2001, 4:30 PM in LAEB B222
Dr. Richard Higgs, Eli Lilly & Company
Statistical Perspectives for Molecular Diversity

Monday, September 17, 2001, 4:30 PM in LAEB B222
Dr. Wendell Smith, Eli Lilly & Company
Statistical Methods in Assay Validation

Monday, September 24, 2001, 4:30 PM in LAEB B222
Dr. Brian Smith, Eli Lilly & Company
Clinical Pharmacology Statistics

Monday, October 1, 2001, 4:30 PM in LAEB B222
Dr. Doug Faries, Eli Lilly & Company
Statistical Issues in Phase II Trials: Reaching a Product Decision

Monday, October 8, 2001
No Seminar
October Break

Monday, October 15, 2001, 4:30 PM in LAEB B222
Dr. Jay Andersen, Eli Lilly & Company
Applications of Decision Analysis in the Pharmaceutical Industry

Monday, October 22, 2001, 4:30 PM in LAEB B222
Dr. Kristi Griffiths, Eli Lilly & Company
A Statistician's Role in Drug Product Development

Monday, October 29, 2001, 4:30 PM in LAEB B222
Wherly P Hoffman, Ph.D. and Daniel Ness, DVM, Ph.D., Eli Lilly & Company
Statistics in Toxicology

Monday, November 5, 2001, 4:30 PM in LAEB B222
Dr. Roy Tamura, Eli Lilly & Company
Comparing the Time to Response in Antidepressant Clinical Trials
Presentation Slides (PowerPoint)

Monday, November 12, 2001, 4:30 PM in LAEB B222
Dr. Bill Huster, Eli Lilly & Company
From Product Decision to Regulatory Submission (and beyond!)

Monday, November 19, 2001, 4:30 PM in LAEB B222
Dr. Bob Obenchain, Eli Lilly & Company
Adjustment for Treatment Selection Bias in Retrospective Studies

Monday, November 26, 2001, 4:30 PM in LAEB B222
Rebecca Elliott, Eli Lilly & Company
Dose Control in Parenteral Manufacturing

Monday, December 3, 2001, 4:30 PM in LAEB B222
Dan Lockhart, Ph.D., Eli Lilly & Company
Applications of Statistics in Pharmaceutical Marketing Research

Last Updated: Aug 31, 2017 9:38 AM

Purdue Department of Statistics, 250 N. University St, West Lafayette, IN 47907

Phone: (765) 494-6030, Fax: (765) 494-0558

© 2015 Purdue University | An equal access/equal opportunity university | Copyright Complaints

Trouble with this page? Disability-related accessibility issue? Please contact the College of Science Webmaster.